Next-Generation Sequencing-Based Molecular Diagnosis of Choroideremia

  title={Next-Generation Sequencing-Based Molecular Diagnosis of Choroideremia},
  author={Kayo Shimizu and Akio Oishi and Maho Oishi and Ken Ogino and Satoshi Morooka and Masako Sugahara and Norimoto Gotoh and Nagahisa Yoshimura},
  journal={Case Reports in Ophthalmology},
  pages={246 - 250}
We screened patients with choroideremia using next-generation sequencing (NGS) and identified a novel mutation and a known mutation in the CHM gene. One patient presented an atypical fundus appearance for choroideremia. Another patient presented macular hole retinal detachment in the left eye. The present case series shows the utility of NGS-based screening in patients with choroideremia. In addition, the presence of macular hole in 1 of the 2 patients, together with a previous report… 

Figures from this paper

Identification of Pathogenic Variants in the CHM Gene in Two Korean Patients With Choroideremia
This is the first report on a molecular genetic diagnosis of choroideremia in Korean individuals and it should be widely adopted for proper diagnosis and the development of new treatment modalities including gene therapy.
Novel CHM mutations in Polish patients with choroideremia – an orphan disease with close perspective of treatment
This study provides the first molecular genetic characteristics of patients with choroideremia from the previously unexplored Polish population.
Panel-Based Next-Generation Sequencing for Inherited Retinal Degenerations in Koreans
  • S. Kim
  • Biology, Medicine
    Essentials in Ophthalmology
  • 2018
In this chapter, recent studies using gene panel-based next-generation sequencing in Korean patients with IRDs will be presented and targeted gene panel sequencing seems to be an efficient approach to find genetic causes of IRDs.
CHM mutation spectrum and disease: An update at the time of human therapeutic trials
Clinical and genetic data from a French cohort of 45 families, 25 of which carry novel variants, are described, in the context of 822 previously reported choroideremia families, where most of the variants represent loss‐of‐function mutations.
Screening for SLC7A14 gene mutations in patients with autosomal recessive or sporadic retinitis pigmentosa
The four SLC7A14 mutations detected herein were unlikely to be pathogenic in this Japanese cohort, and these mutations may be rare in Japanese patients.
Repair of Rhegmatogenous Retinal Detachment in Choroideremia Secondary to Posterior Extramacular Retinal Hole.
A 23-year-old man with choroideremia with a near-total rhegmatogenous retinal detachment was presented with vitrectomy, perfluorooctane to confirm the absence of any peripheral breaks, endolaser, and 20% sulfur hexafluoride gas.


REP-1 gene mutations in Japanese patients with choroideremia
The results show that REP-1 gene defects cause CHM in Japanese patients, and the mutations in these Japanese patients differed from the mutations reported for CHM patients in Europe, Canada, and America except for R267X and 1313delTC.
Cloning of a gene that is rearranged in patients with choroideraemia
Findings provide strong evidence that the gene underlying choroideraemia, a common form of X-linked blindness, is cloned and elucidation of its function should provide new insights into the molecular mechanisms responsible for this disorder and other hereditary retinopathies.
Choroideremia: A review of general findings and pathogenesis
An overview of the clinical features, visual function, biochemistry, histology, molecular genetics, pathogenesis, diagnosis and treatment of CHM is given.
Clinical diagnoses that overlap with choroideremia.
Comprehensive molecular diagnosis of a large cohort of Japanese retinitis pigmentosa and Usher syndrome patients by next-generation sequencing.
By screening a large cohort of patients, this study catalogued the genetic variations involved in RP and Usher syndrome in a Japanese population and highlighted the different distribution of causative genes among populations.
Microarray-based mutation analysis of the ABCA4 (ABCR) gene in autosomal recessive cone–rod dystrophy and retinitis pigmentosa
It is shown that the ABCA4 mutation chip is an efficient first screening tool for arCRD.
Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year.
The safety and efficacy of human retinal gene transfer with rAAV2-RPE65 vector extends to at least 1 year posttreatment, and the remarkable improvements in visual sensitivity reported by 3 months were unchanged at 12 months.
The promise of whole-exome sequencing in medical genetics
In this review, the impacts of WES in medical genetics as well as its consequences leading to improve health care are summarized.